Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT
- PMID: 22785518
- DOI: 10.1097/RLU.0b013e3182485361
Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT
Abstract
Two women presented with abdominal complaints; after clinical investigation and ultrasonography, both were suspected of having (ovarian) teratoma. The CT scan showed enlarged para-aortic lymph nodes, which increased the suspicion of a malignant process. Total-body 18F-FDG PET/CT studies helped to differentiate benign from malignant ovarian teratoma, as well as abdominal lymphadenopathy, subsequently confirmed by histopathology. When there is suspicion of a malignant teratoma, 18F-FDG PET/CT may help in accurate diagnosis and staging; as for malignant disease (either malignant transformation of mature cystic teratoma or malignant immature teratoma), a more aggressive, multimodality approach may be indicated.
Similar articles
-
The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.Int J Clin Oncol. 2015 Oct;20(5):960-6. doi: 10.1007/s10147-015-0800-0. Epub 2015 Feb 15. Int J Clin Oncol. 2015. PMID: 25681878
-
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.Nucl Med Commun. 2007 Aug;28(8):589-95. doi: 10.1097/MNM.0b013e3281afa256. Nucl Med Commun. 2007. PMID: 17625380 Clinical Trial.
-
18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.Clin Nucl Med. 2016 Feb;41(2):e104-6. doi: 10.1097/RLU.0000000000001046. Clin Nucl Med. 2016. PMID: 26545025
-
FDG-PET/CT as a molecular biomarker in ovarian cancer.Cancer Biomark. 2010-2011;8(4-5):167-75. doi: 10.3233/CBM-2011-0219. Cancer Biomark. 2010. PMID: 22045351 Review.
-
Present and future of FDG-PET/CT in ovarian cancer.Ann Nucl Med. 2011 Apr;25(3):155-64. doi: 10.1007/s12149-010-0449-8. Epub 2010 Nov 27. Ann Nucl Med. 2011. PMID: 21113691 Review.
Cited by
-
The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.Int J Clin Oncol. 2015 Oct;20(5):960-6. doi: 10.1007/s10147-015-0800-0. Epub 2015 Feb 15. Int J Clin Oncol. 2015. PMID: 25681878
-
18F FDG positron-emission tomography findings of gliomatosis peritonei: A case report and review of the literature.Gynecol Oncol Rep. 2017 Mar 27;20:105-107. doi: 10.1016/j.gore.2017.03.018. eCollection 2017 May. Gynecol Oncol Rep. 2017. PMID: 28393096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical